Ranked by engagement
Top topics — all time page 3
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 3 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it before…
|
+126 | 138 | 31k | 17mo |
|
Reading a trial's population section before its results — does this still hold?
Reading a trial's population section before its results — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen STEP 1 ( N Engl J Med ,…
|
+140 | 154 | 5.4k | 14mo |
|
Managing an unplanned gap in supply — what changed since
On the subject in the title: Managing an unplanned gap in supply — what changed since Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
+114 | 124 | 54k | 8mo |
|
A supplier that answers analytical questions with restated claims
On the subject in the title: A supplier that answers analytical questions with restated claims Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+107 | 118 | 45k | 12mo |
|
Biased agonism: a real phenomenon, an over-used explanation
Posting this under the heading it deserves: Biased agonism: a real phenomenon, an over-used explanation Everything below is what sits behind that. A documentation question rather than an analytical one. I…
|
+130 | 135 | 23k | 16mo |
|
Promotion criteria, and the one that stops most nominations
Promotion criteria, and the one that stops most nominations — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic…
|
+135 | 146 | 17k | 19mo |
|
Adjudicated events and why the definition matters — the long version
Adjudicated events and why the definition matters — the long version Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021) with STEP 4 ( JAMA…
|
+125 | 146 | 13k | 15mo |
|
Tracking a preprint to publication: a worked example
Tracking a preprint to publication: a worked example Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl J Med , 2021). Please read it before…
|
+133 | 147 | 15k | 7mo |
|
Seven-day rolling means and why weekly readings mislead
Seven-day rolling means and why weekly readings mislead Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost…
|
+109 | 125 | 42k | 10h |
|
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version
On the subject in the title: A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…
|
+160 | 165 | 1.9k | 12mo |
|
Charge states for a 4 kDa peptide, worked through
On the subject in the title: Charge states for a 4 kDa peptide, worked through Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+124 | 146 | 15k | 16mo |
|
A ten-fold dose error caught before injection — one year on
On the subject in the title: A ten-fold dose error caught before injection — one year on Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same…
|
+151 | 157 | 9.4k | 12mo |
|
Delayed gastric emptying and oral medication absorption: which drugs matter
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…
|
+110 | 116 | 43k | 14mo |
|
Trifluoroacetate content and its consequences
Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me…
|
+123 | 134 | 31k | 5mo |
|
Racemisation and why it is invisible to a mass measurement
Posting this under the heading it deserves: Racemisation and why it is invisible to a mass measurement Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
+120 | 127 | 41k | 1mo |
|
Request: a diff view for wiki revisions — the long version
Posting this under the heading it deserves: Request: a diff view for wiki revisions — the long version Everything below is what sits behind that. Process question about how this site works. I have read the…
|
+96 | 104 | 61k | 6mo |
|
Substitution between formats during a shortage
On the subject in the title: Substitution between formats during a shortage Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
|
+114 | 123 | 47k | 7mo |
|
[2026 update] What steady state means for the decision to escalate
The question in the title: What steady state means for the decision to escalate I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still have a…
|
+127 | 137 | 32k | 8mo |
|
A reconstituted vial's beyond-use date and the reasoning behind common figures
Posting this under the heading it deserves: A reconstituted vial's beyond-use date and the reasoning behind common figures Everything below is what sits behind that. Practical question with the units stated,…
|
+125 | 129 | 45k | 2mo |
|
Reconstituting a multi-strength kit without mixing yourself up
Reconstituting a multi-strength kit without mixing yourself up Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen…
|
+108 | 123 | 30k | 11mo |
|
Follow-up: Why the titration planner refuses to produce a schedule below a floor
The question in the title: Why the titration planner refuses to produce a schedule below a floor I will give what I have already checked below so nobody repeats it. I would like to understand what this number…
|
+120 | 146 | 14k | 10mo |
|
Thyroid function tests during substantial weight change
Posting this under the heading it deserves: Thyroid function tests during substantial weight change Everything below is what sits behind that. General question, not a request for advice about my own care — I…
|
+136 | 149 | 3.3k | 8mo |
|
[2026 update] Charge states for a 4 kDa peptide, worked through
On the subject in the title: Charge states for a 4 kDa peptide, worked through Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. semaglutide has a…
|
+116 | 135 | 31k | 3mo |
|
Why we hide unevidenced fraud accusations and log the hiding
Why we hide unevidenced fraud accusations and log the hiding — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a…
|
+97 | 106 | 63k | 14mo |
|
Distinguishing a deletion sequence by mass alone
Distinguishing a deletion sequence by mass alone Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+121 | 129 | 25k | 17mo |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
|
+99 | 110 | 61k | 2d |
|
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile
Posting this under the heading it deserves: Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with…
|
+119 | 141 | 22k | 20mo |
|
Counter-ion form: the field almost nobody reports — one year on
On the subject in the title: Counter-ion form: the field almost nobody reports — one year on Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a…
|
+121 | 139 | 31k | 16mo |
|
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how confident we can be
The question in the title: What the GIP component of tirzepatide is thought to contribute, and how confident we can be I will give what I have already checked below so nobody repeats it. Comparing STEP 4 (…
|
+109 | 124 | 31k | 10mo |
|
[2026 update] An appeal that failed, and what I would do differently
Posting this under the heading it deserves: An appeal that failed, and what I would do differently Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
|
+152 | 159 | 2.5k | 13mo |